MLYS (Mineralys Therapeutics, Inc.) operates in the Health technology sector. It's currently trading at $30.46. Our composite momentum score rates it 72/110 based on price +3.0% (1d), rsi 58.6 — bullish momentum sweet spot, roc9 +12.4% — sharp acceleration, macd 0.0 — bullish, beta 1.67 — high beta, and analyst: strong buy. Up 10.0% across 2 tracked price points, from Jul 7, 2026 to Jul 7, 2026.